Referred to the Committee on Small Business, and in addition to the Committee on Science, Space, and Technology, for a period to be subsequently determined by the Speaker, in each case for consideration of such provisions as fall within the jurisdiction of the committee concerned.
The SBIR/STTR Pilot Extension Act extends several federal programs that support small businesses in research and innovation. The bill extends the "direct to Phase II" pilot program—which allows federal agencies to skip the initial Phase I stage and fund promising small business research projects directly—through fiscal year 2030 (currently set to expire in 2025) and expands it so all federal agencies running SBIR programs can participate, not just the National Institutes of Health, Department of Defense, and Department of Education. The bill also extends two other small business innovation programs—the Phase 0 proof of concept partnership program and the commercialization assistance pilot programs—through September 30, 2030. To prevent overuse, the legislation caps direct-to-Phase II awards at 10 percent of each agency's total SBIR funding (15 percent for NIH), and requires agencies to report on how many awards they issue under this authority. These changes primarily benefit small businesses seeking federal research funding and the federal agencies administering these innovation programs.
Take Action
Your position
Add a comment
to comment on this bill.
Annotate the text
Highlight any passage on the Summary or Full Text tab to attach a note. Annotations appear on the Annotations tab.